LEADING MED
TENDOVIS
LEADING MED
TENDOVIS
Medical Device
LEADING MED
TENDOVIS
Medical Device
Soft tissue adapted biocompatible Hyaluronic Acid
TendoVis is indicated for periarticular infiltrations in cases of damaged or compromised tendons and ligaments.
– modulates inflammation
– reduces pain
– protects and supports the injured area
– lowers the risk of recurrence
– shortens recovery times
– promotes proper tendon realignment, leading to functional recovery.
TendoVis is a sterile glass syringe containing Sodium Hyaluronate, with pH and osmolarity biocompatible with soft tissues. It is therefore suitable for periarticular injection, specifically in the soft tissues surrounding tendons and ligaments.
TendoVis is indicated for patients with rotator cuff tendinopathy, epicondylitis, and ankle sprains. Thanks to a sophisticated patented production process (STABHA patent – Soft Tissue Adapted Biocompatible Hyaluronic Acid), it ensures prolonged retention time and prevents degradative reactions by the body.
*The I.D.E.H.A. Study Intra-articular Double Molecular Weight Efficacy of Hyaluronic Acid
Authors: Dr. Romeo Gatti, Xuming Shen – IDEHA Group
Patients: patients in Italy (Multicenter study involving over 50 physicians) PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24416477
SAFETY AND EFFECTIVENESS IN PAIN REDUCTION
Long term efficacy and safety of a combined low and high molecular weight hyaluronic acid in the treatment of osteoarthritis of the knee
Authors: Robert J. Petrella, Joseph Decaria, Michael Petrella
PubMed: http://www.pagepress.org/journals/index.php/rr/article/view/rr.2011.e4/2729
EULAR ROME 2010
LONG-TERM EFFECTIVENESS (12–24 MONTHS) AND GREATER EFFICACY COMPARED TO CONVENTIONAL THERAPIES
Efficacy of DualVis (Renehavis) for Knee Osteoarthritis in Indonesia
Authors: Prof. Handono Kalim, Dr. Arif Sumardjono, Dr. Nyimas Fatimah.
Soft tissue adapted biocompatible Hyaluronic Acid

TendoVis is indicated for periarticular infiltrations in cases of damaged or compromised tendons and ligaments.
– modulates inflammation
– reduces pain
– protects and supports the injured area
– lowers the risk of recurrence
– shortens recovery times
– promotes proper tendon realignment, leading to functional recovery.
TendoVis is a sterile glass syringe containing Sodium Hyaluronate, with pH and osmolarity biocompatible with soft tissues. It is therefore suitable for periarticular injection, specifically in the soft tissues surrounding tendons and ligaments.
TendoVis is indicated for patients with rotator cuff tendinopathy, epicondylitis, and ankle sprains. Thanks to a sophisticated patented production process (STABHA patent – Soft Tissue Adapted Biocompatible Hyaluronic Acid), it ensures prolonged retention time and prevents degradative reactions by the body.
*The I.D.E.H.A. Study Intra-articular Double Molecular Weight Efficacy of Hyaluronic Acid
Authors: Dr. Romeo Gatti, Xuming Shen – IDEHA Group
Patients: 1,214 patients in Italy (Multicenter study involving over 50 physicians) PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24416477
SAFETY AND EFFECTIVENESS IN PAIN REDUCTION
Long term efficacy and safety of a combined low and high molecular weight hyaluronic acid in the treatment of osteoarthritis of the knee
Authors: Robert J. Petrella, Joseph Decaria, Michael Petrella
PubMed: http://www.pagepress.org/journals/index.php/rr/article/view/rr.2011.e4/2729
EULAR ROME 2010
LONG-TERM EFFECTIVENESS (12–24 MONTHS) AND GREATER EFFICACY COMPARED TO CONVENTIONAL THERAPIES
Efficacy of DualVis (Renehavis) for Knee Osteoarthritis in Indonesia
Authors: Prof. Handono Kalim, Dr. Arif Sumardjono, Dr. Nyimas Fatimah.
REQUEST INFORMATION
REQUEST INFORMATION